Corient Private Wealth LP Acquires 227,947 Shares of Edwards Lifesciences Corporation $EW
MarketBeat
Corient Private Wealth LP significantly increased its stake in Edwards Lifesciences Corporation by over 1,000%, acquiring an additional 227,947 shares. This move is part of a broader trend of institutional investors, including California State Teachers Retirement System and BlackRock Inc., increasing their holdings in the medical research company. The article also details recent analyst ratings, insider trading activity, and positive news regarding CMS expanding TAVR coverage, which is expected
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.